FiercePharma

The Oral GLP-1 Tracker: 'Familiarity' with Wegovy has helped Novo control oral obesity market

Tracking the oral GLP-1 market battle between Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo. (Hase-Hoch-2/iStock/Getty Images Plus) With the recent launches ...